ReviewInternational journal of nanomedicine2025
Nanozymes for Accelerating the Foot Wound Healing: A Review.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Artificial intelligence-guided nanozyme engineering for chronic wound healing: from rational design to precision therapeutics.Bioactive materials · 2027Review
- The role of nanoparticles in the treatment of diabetic foot ulcers: mechanisms, delivery platforms, translational challenges, and future directions.Discover nano · 2026Review
- Immunomodulatory Nanozymes as Programmable Redox-Immune Set-Point Regulators.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Exploring Tetrazolium Salt Reduction by Mono- and Bimetallic Nanoparticles as an Alternative Signal-Generation Strategy for Point-of-Care Diagnostics.Biosensors · 2026Article
- Advanced Functional Wound Dressings in Precision Surgery: Immunometabolic Reprogramming, Bioadaptive Biomaterials, and Intelligent Regenerative Interfaces.International journal of molecular sciences · 2026Review
- Review
- Metal-Functionalized Nanozymes in Antibacterial Wound Management: Recent Advances and Future Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
- The mechanism and application ofFrontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic foot is a most common and life-threatening complication of diabetes. It often results in a protracted course of wound healing. Currently, treatments for diabetic foot include wound dressings, antibiotics, and debridement. However, these treatments are often inadequate due to the complexity of diabetic foot. Various adjuvant therapies are currently under investigation to accelerate wound healing. In recent years, the emergence of nanozymes, nanomaterial with natural enzyme-like characteristics and activities, have attracted much attention. As a promising candidate in biomedicine, the breadth of application is growing fast, with different mechanisms for accelerating wound healing, such as antioxidant effects, antibacterial effects, promotion of angiogenesis, and regulation of the wound microenvironment. Faced with the inherent defects of nanozyme, new multifunctional nanozymes composite materials have also been continuously developed to achieve synergistic effects with various types of enzymatic activities. This is a new strategy for diabetic foot wound healing in the future. This review summarizes current knowledge about nanozymes and their potential mechanisms in diabetic wound healing. An overview of progress in the applied research on these nanozymes, current challenges and future perspectives of nanozymes in related fields of diabetic wound healing is also discussed to stimulate new strategies and preclinical translations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.